Lovaltech
- Biotech or pharma, therapeutic R&D
Lovaltech is a French DeepTech start-up created in 2022 to pursue an ambitious research project by the University of Tours and INRAE.
We are committed to the industrial development of a new generation of nasally-administered protein vaccines, and our first vaccine is starting clinical trials phase I&II (https://clinicaltrials.gov/study/NCT06821126)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}